Effect of route of inoculation on humoral immune response of White Leghorn chickens selected for high or low antibody response to sheep red blood cells.
Effects of route of SRBC inoculation and antigen dosage on primary and secondary antibody response of White Leghorn lines selected for high (HA) or low (LA) 5-d antibody response to a single i.v. inoculation with 0.1 mL of a 0.25% suspension of SRBC were studied in two trials. In the first trial, chicks from parents of generation S24 of each line were randomly assigned to one of four treatments. At 35 d of age, they were inoculated into the brachial vein with 0.1 mL of 0.25% suspension of SRBC or into the breast muscle with 0.1 mL of 0.25, 2.50, or 25.00% SRBC. Plasma SRBC antibody was measured 3, 6, 10, and 20 d later. In the second trial, chicks from parents of generation S25 of each line were randomly assigned to treatment groups. At 28 d of age they were inoculated with 0.1 mL of 0.25% SRBC into the brachial vein, 0.1 mL of 25.00% SRBC into the thigh (T-L) or breast muscle (B-L), or 0.5 mL of 25.00% SRBC into the thigh (T-H) or breast muscle (B-H). Twenty-one days later, chicks (except five per group) were given a booster inoculation of 0.1 mL of 25.00% SRBC into the thigh muscle. Six and 10 d after each inoculation, plasma SRBC antibody, IgG, and IgM titers were measured. The SRBC antibody titers after primary i.v. inoculation with SRBC were always higher for HA than LA chicks. When inoculations were i.m., differences between lines varied with dosage. Low dosages inoculated into the breast failed to induce line differences consistently, whereas at higher dosages, titers were greater for HA than LA chicks regardless of inoculation site. For Line LA, inoculation into the thigh elicited higher titers than inoculations into the breast. Antibody titers to the booster inoculation of SRBC were similar for the lines.
Boa-Amponsem
K
K
Animal and Poultry Sciences Department, Virginia Polytechnic Institute and State University, Blacksburg 24061, USA.
Price
S E
SE
Dunnington
E A
EA
Siegel
P B
PB
D000818:Animals; D000917:Antibody Formation; D000941:Antigens / Q000008:administration & dosage* / Q000276:immunology; D002645:Chickens / Q000097:blood / Q000235:genetics / Q000276:immunology*; D004306:Dose-Response Relationship, Immunologic; D004912:Erythrocytes / Q000276:immunology*; D007114:Immunization / Q000662:veterinary; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007273:Injections, Intramuscular / Q000379:methods / Q000662:veterinary; D007275:Injections, Intravenous / Q000379:methods / Q000662:veterinary; D012756:Sheep
D000941:Antigens; D007074:Immunoglobulin G; D007075:Immunoglobulin M